HTB homepage • Conference reports • Articles by subject • Subscribe 28 March 2019 Contents Editorial 29 March 2019: vol 20 no 4 – second CROI reports Conference reports Conference on Retroviruses and Opportunistic Infections (CROI 2019): second reports Maturation inhibitor GSK’232 reduces viral load by –1.5 log at day 10 Capsid inhibitor GS-6207 shows potential for 3-monthly injections First phase 1 results from bNAb PGT121 in HIV positive people Dolutegravir/3TC dual ART is as effective at lowest viral load cut-off as triple therapy in GEMINI studies Same-day ART is effective in San Francisco Rapid-ART clinic Integrase inhibitors and neural tube defects: more data still needed Double-dose levonorgestrel implant does not overcome interaction with efavirenz Efavirenz and rifampicin together reduce levels of injectable contraception Bedaquiline and delamanid safe when given together to treat drug resistant TB Isoniazid preventative therapy in HIV positive pregnant women not linked to poor outcomes Pregnancy Dear Doctor letter: Increased risk of treatment failure and increased risk of mother-to-child transmission of HIV infection dues to lower exposure of elvitegravir and cobicistat during the second and third trimesters of pregnancy PDFs 29 March 2019 vol 20 no 4 HTB homepage • Conference reports • Articles by subject • Subscribe
